Cycurion is trading at $2.63, up 9.58%, with no verified company-specific announcement explaining its November 2 pre-market rise.
- The prior close was $2.40.
- Cycurion’s latest confirmed update, on October 22, said it would discuss third-quarter results on November 16; it did not report new earnings.
- A search-result report about an expanded public-health partnership was not independently evaluated. Supplied index moves were mixed and modestly positive, offering no clear explanation for the sharp rise.